The higher proportion but relatively low incidence of HER2+ tumors in Kurdish women appears to correspond to the Finnish data and does not indicate an increased risk of developing HER2+ breast cancers in younger women but rather a low risk of developing favorable ER+/HER2- tumors after the menopause. The gene discussed is ESR1; the disease is breast cancer.